PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Multiple Benefits of NAT Boosts Uptake of NAT Reagents for Clinical Applications in Europe - Nucleic acid-based amplification technique (NAT) has allowed the highly specific detection and quantification of extremely low levels of disease agents. This has supported effective therapeutic management through the monitoring of patients
Multiple Benefits of NAT Boosts Uptake of NAT Reagents for Clinical Applications in Europe

 

NewswireToday - /newswire/ - London, United Kingdom, 2008/06/24 - Nucleic acid-based amplification technique (NAT) has allowed the highly specific detection and quantification of extremely low levels of disease agents. This has supported effective therapeutic management through the monitoring of patients.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

New analysis from Frost & Sullivan (drugdiscovery.frost.com), European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications, finds that the market earned revenues of $432.0 million in 2007 and estimates this to reach $1,153.0 million in 2014.

"The increase in automation technology and the use of quantitative PCR (qPCR) and multiplexing provides an early, rapid and accurate method to diagnose disease states and medical disorders," notes Frost & Sullivan Research Analyst Bela Sheth. "End users are slowly realising the benefits of being able to detect clinically relevant genetic variations in patients to help doctors better predict disease risk and progression. This allows them to select the most appropriate therapy sooner, which can decrease healthcare costs significantly in the long- term."

There are several tests for infectious diseases that use NAT technology, including for HIV, HBV, HCV, HPV, CT, GC, HSV, CMV, MTB, Legionella species, Mycloplasma pneumoniae, Group A strep, EBV and VZV. The sensitivity and the accuracy of NAT technology and the rise in automation are driving the growth of this segment.

NAT technology for genetic testing is still in its early growth stage, however the completion of the human genome project and the increase in the number of biomarkers that are being identified is catalysing this market. The development of NAT tests for screening purposes, such as for HPV testing and expanded DTC advertising, augurs well for long-term market growth.

However, reimbursement is a key issue in several European countries. While end users have started to recognise the benefits of using NAT technology, the high costs associated with instrumentation and reagents constitute a major concern.

"NAT diagnostic kits can play a very important part in detecting infectious agents, genetic disorders, predicting the likelihood of having cancer and monitoring a therapy," explains Sheth. "However, the major question gripping the industry is whether these technologies are cost effective. The alternative methods for clinical applications such as home-brewed assays, immunoassays, fluorescence in situ hybridisation (FISH) and culture techniques continue to be less expensive than NAT reagents."

With the wide range of alternative technology available in the market to detect infectious agents and medical disorders, price has always been a sensitive issue with regards to NAT technology.

"Therefore, strategies such as educating end users and undertaking widespread marketing to make customers aware of NAT products and their benefits can be useful," advises Sheth. "Focusing on automation and multi-parameter kits can encourage the use of this technology, and promote sustained market growth."

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the European NAT reagents market for clinical applications, then send an email to Patrick Cairns, Corporate Communications, at pcairns_pr[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.

European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications is part of the Drug Discovery Technologies Growth Partnership Service Programme, which also includes research in the following markets: Contract Research Organisations (CROs) Markets in Europe, Nucleic Acid Isolation Markets in Europe and Advances in Laboratory Automation Markets in Europe. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications / M218

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Multiple Benefits of NAT Boosts Uptake of NAT Reagents for Clinical Applications in Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Patrick Cairns 
+27 18 468 2315 patrick.cairns[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)